ABIVAX (EPA:ABVX) | Finanzwire

Basculer en Français

9475	Companies
185441	Keywords
117779	Articles
99295	Press releases

Home
Companies
ABIVAX

BRIEF

published on 06/11/2025 at 22:05, 5 months 23 days ago

Abivax Reports Outcomes of Annual General Meeting

Financial Results Biotechnology Abivax Annual Meeting Board Appointments
PRESS RELEASE

published on 06/11/2025 at 22:00, 5 months 23 days ago

Abivax Announces Results of its June 6, 2025 Annual General Meeting
Abivax announced the results of its June 6, 2025 Annual General Meeting. Shareholders adopted all proposed resolutions including financial statements and appointments. More details on the vote results available on the Company's website

Annual General Meeting Shareholders Appointments Abivax Resolutions
PRESS RELEASE

published on 06/11/2025 at 22:00, 5 months 23 days ago

Abivax Announces Results of its June 6, 2025 Annual General Meeting
Abivax announces successful outcomes of its Annual General Meeting on June 6, 2025, including adoption of resolutions and appointments. Details on www.abivax.com

Annual General Meeting Appointments Abivax Resolutions Therapeutics
PRESS RELEASE

published on 06/11/2025 at 22:00, 5 months 23 days ago

Abivax Announces Results of its June 6, 2025 Annual General Meeting
Abivax announces successful results of its 2025 Annual General Meeting with approval of key resolutions including financial statements and board appointments

Annual General Meeting Shareholders Abivax AGM Results
BRIEF

published on 06/02/2025 at 22:05, 6 months 2 days ago

Abivax Reports Q1 2025 Financial Results

Cash Position Operating Loss R&D Expenses Q1 2025 Results Abivax Financials
PRESS RELEASE

published on 06/02/2025 at 22:00, 6 months 2 days ago

Abivax Presents First Quarter 2025 Financial Results
Abivax presents first quarter 2025 financial results, reporting operating loss increase to EUR -47.2M, R&D expenses growth, net loss of EUR -52.4M, and cash position at EUR 103.6M

Financial Results Cash Position Abivax Operating Loss R&D Expenses
BRIEF

published on 05/14/2025 at 18:05, 6 months 21 days ago

ABIVAX: Number of shares and voting rights as of April 30, 2025

Voting Rights Actions Abivax AMF Regulations Financial Transparency
BRIEF

published on 04/29/2025 at 22:10, 7 months 5 days ago

Abivax Completes Enrollment for Phase 3 Ulcerative Colitis Trials

Abivax Obefazimod Ulcerative Colitis Phase 3 Trials Clinical Enrollment
PRESS RELEASE

published on 04/29/2025 at 22:05, 7 months 5 days ago

Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis
Abivax completes enrollment for Phase 3 ABTECT Trials in patients with active ulcerative colitis. Top-line results expected in Q3 2025, NDA submission planned for H2 2026

Abivax Ulcerative Colitis Phase 3 ABTECT Trials NDA Submission
BRIEF

published on 04/22/2025 at 22:10, 7 months 12 days ago

Abivax: Terms of the Annual General Meeting and outlook for 2025

Biotechnology Abivax Clinical Trials Investment General Meeting 2025

Accesswire

Published on 12/05/2025 at 02:35, 8 hours 46 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 8 hours 51 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 10 hours 21 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 12 hours 16 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 12 hours 21 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 11:14, 7 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 10:30, 51 minutes ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 1 hour 6 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 1 hour 41 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 51 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany

Les Echos

Published on 12/05/2025 at 08:45, 2 hours 36 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 17 hours 21 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 17 hours 36 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 17 hours 37 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 4 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE